IP Library Granted Patent US 7,790,385
Granted Patent B2
US 7,790,385 · App. 11/770,659 · Granted Sep 7, 2010

Abasic site endonuclease assay

Assignee: Elitech Holding B.V.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,790,385
App. No.
11/770,659
Granted
Sep 7, 2010
Kind
B2
Abstract

The present invention provides a novel method for detection and/or genotyping of nucleic acids that utilizes the specificity of an AP endonuclease. In addition, the present invention provides a novel method for nucleic acid amplification.

Claims (26)

1. A kit comprising an AP site probe comprising an oligonucleotide NA that hybridizes to a target nucleic acid, a quencher molecule attached to the NA, and a functional tail R comprising a detectable reporter group, said functional tail R attached via a hydroxyprolinol linker, which is attached via a phosphodiester bond of a phosphate group to the 3′ terminal nucleotide of the NA, wherein the reporter group is not detected when the functional tail R is attached to the NA.

2. The kit of claim 1 , wherein the NA of said AP site probe is 3-200 nucleotides in length.

3. The kit of claim 1 , wherein the NA of said AP site probe is 3-100 nucleotides in length.

4. The kit of claim 1 , wherein the NA of said AP site probe is 5-30 nucleotides in length.

5. The kit of claim 1 , wherein said AP site probe comprises at least one modified base.

6. The kit of claim 1 , wherein the reporter group is a fluorophore.

7. The kit of claim 1 , further comprising an enhancer oligonucleotide, wherein the 5′-end of said enhancer oligonucleotide hybridizes to the target nucleic acid on the 3′ side of the hybridized AP site probe, wherein a gap of 1, 2 or 5 unpaired bases resides between the enhancer oligonucleotide and the AP site probe hybridization locations with the target nucleic acid.

8. The kit of claim 1 , wherein the quencher molecule is attached to the 5′ end of the NA of said AP site probe via a non-cleavable linker.

9. The kit of claim 7 , wherein said AP site probe is covalently linked to the 3′ end of said enhancer.

10. The kit of claim 7 , wherein said enhancer is 3 to 50 nucleotides in length.

11. The kit of claim 7 , wherein said enhancer is 5 to 30 nucleotides in length.

12. The kit of claim 1 , further comprising an AP endonuclease.

13. The kit of claim 12 , wherein the AP endonuclease is a Class II AP endonuclease.

14. The kit of claim 13 , wherein the Class II AP endonuclease is an E. coli Endonuclease IV.

15. The kit of claim 1 , wherein said target nucleic acid is a product of an amplification reaction.

16. The kit of claim 15 , wherein said amplification reaction is polymerase chain reaction.

17. The kit of claim 16 , wherein said polymerase chain reaction uses a thermostable endonuclease.

18. The kit of claim 15 , wherein said amplification reaction is an isothermal amplification reaction.

19. The kit of claim 1 , further comprising a second AP site probe, wherein said first probe comprises a NA portion comprising at least one base difference from the NA portion of said second probe, and wherein said first probe comprises a reporter group that is distinguishably detectable from the reporter group of said second probe.

20. The kit of claim 19 , wherein the reporter group of said first probe and said second probe comprises a fluorophore, and wherein the fluorophore of said first probe comprises a distinguishably detectable emission wavelength from the fluorophore of said second probe.

21. The kit of claim 19 , wherein said at least one base difference between the NA of said first probe and the NA of said second probe comprises a base difference at position 1, 2, 3 or 4 from the 3′ end of said probes.

22. The kit of claim 19 , wherein said at least one base difference between the NA of said first probe and the NA of said second probe comprises a base difference at position 1 or 2 from the 3′ end of said probes.

23. The kit of claim 1 , further comprising a plurality of AP site probes, wherein the NA portion of said probes are members of a universal library of about 5-8 nucleotides in length.

24. The kit of claim 23 , wherein each AP site probe member comprises at least one modified base.

25. The kit of claim 24 , wherein the modified base is selected from the group consisting of 5-hydroxybutynyl uridine; 4-(4,6-Diamino-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-but-3-yn-1-ol; 4-amino-1H-pyrazolo[3,4-d]pyrimidine; 5-(4-Hydroxy-but-1-ynyl)-1H-pyrimidine-2,4-dione; 6-amino-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one; and 4-hydroxy-6-amino pyrazolopyrimidine.

26. The kit of claim 24 , wherein the modified base is selected from the group consisting of a phosphothioate, a methylphosphonate, a sulfamate, a polyamide and a locked nucleic acid.

Assignments (5)
NUNC PRO TUNC ASSIGNMENT Recorded Jan 11, 2022
From: ELITECHGROUP, INC.
To: ELITECHGROUP MDX LLC
Reel/Frame 058615/0341 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2019
From: ELITECHGROUP B.V.
To: ELITECHGROUP, INC.
Reel/Frame 048078/0553 →
CHANGE OF NAME Recorded Mar 10, 2017
From: ELITECH HOLDING BV
To: ELITECHGROUP B.V.
Reel/Frame 041974/0867 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2017
From: EPOCH BIOSCIENCES, INC.
To: ELITECH HOLDING BV
Reel/Frame 041925/0808 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2009
From: NANOGEN, INC.; EPOCH BIOSCIENCES, INC.; NANOTRONICS, INC.
To: ELITECH HOLDING B.V.
Reel/Frame 023260/0182 →
Continuity (3)
Continuation 1064535300 · Aug 20, 2003
Provisional Application 6040564200 · Aug 21, 2002
Related Publication 20080166782A1 · Jul 10, 2008